Cytogenetics in pre-B and B-cell acute lymphoblastic leukemia: a study of 208 patients diagnosed between 1981 and 2008

Cancer Genetics and Cytogenetics

Volumn 200, Issue 1, 2010, Pages 8-15

  De Braekeleer, Etienne ^a,b,c   Basinko, Audrey ^a,b,c   Douet Guilbert, Nathalie ^a,b,c   Morel, Frédéric ^a,b,c   Le Bris, Marie Josée ^c   Berthou, Christian ^a,c   Morice, Patrick ^d   Férec, Claude ^a,b,c   De Braekeleer, Marc ^a,b,c  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b INSERM   (France)

^c CHU MORVAN   (France)

^d Clinical Hematology Service   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HYPERDIPLOIDY; KARYOTYPE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDODIPLOIDY; RELAPSE; SCHOOL CHILD; STRUCTURAL CHROMOSOME ABERRATION;

ADOLESCENT; ADULT; AGED; CHROMOSOME ABERRATIONS; HUMANS; LEUKEMIA, B-CELL; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TIME FACTORS; TRANSLOCATION, GENETIC;

EID: 77953336132     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.03.004     Document Type: Article

References (56)

1. Moorman A.V., Harrison C.J., Buck G.A., Richards S.M., Secker-Walker L.M., Martineau M., et al. Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALL XII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007, 109:3189-3197.
2. Pullarkat V., Slovak M.L., Kopecky K.J., Forman S.J., Appelbaum F.R. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood 2008, 111:2563-2572.
3. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., et al. European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 1995, 9:1783-1786.
4. Morel F., Le Bris M.J., Douet-Guilbert N., Duchemin J., Herry A., Le Calvez G., et al. Insertion of chromosome 11 in chromosome 4 resulting in a 5' MLL-3' AF4 fusion gene in a case of adult acute lymphoblastic leukemia. Cancer Genet Cytogenet 2003, 145:74-77.
5. ISCN 1995: an international system for human cytogenetic nomenclature (1995) 1995, S. Karger, Basel. F. Mitelman (Ed.).
6. Douet-Guilbert N., Morel F., Le Bris M.J., Herry A., Le Calvez G., Marion V., et al. A fluorescence in situ hybridization study of TEL-AML1 fusion in B-cell acute lymphoblastic leukemia (1984-2001). Cancer Genet Cytogenet 2003, 144:143-147.
7. Lafage-Pochitaloff M., Charrin C. Cytogenetic abnormalities in acute lymphoblastic leukemia [In French]. Pathol Biol (Paris) 2003, 51:329-336.
8. Kebriaei P., Anastasi J., Larson R.A. Acute lymphoblastic leukaemia: diagnosis and classification. Best Pract Res Clin Haematol 2002, 15:597-621.
9. Udayakumar A.M., Bashir W.A., Pathare A.V., Wali Y.A., Zacharia M., Khan A.A., et al. Cytogenetic profile of childhood acute lymphoblastic leukemia in Oman. Arch Med Res 2007, 38:305-312.
10. Harrison C.J. Acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2001, 14:593-607.
11. Mrózek K., Heerema N.A., Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 2004, 18:115-136.
12. Ferrando A.A., Look A.T. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000, 37:381-395.
13. Harrison C.J. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev 2001, 15:49-59.
14. Harrison C.J. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009, 144:147-156.
15. Paulsson K., Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009, 48:637-660.
16. Aldrich M.C., Zhang L., Wiemels J.L., Ma X., Loh M.L., Metayer C., et al. Cytogenetics of Hispanic and white children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev 2006, 15:578-581.
17. Harrison C.J., Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002, 6:91-113.
18. Secker-Walker L.M., Lawler S.D., Hardisty R.M. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 1978, 2:1529-1530.
19. Faderl S., Kantarjian H.M., Talpaz M., Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998, 91:3995-4019.
20. Chessels J.M., Swansbury G.J., Reeves B., Bailey C.C., Richards S.M. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Br J Haematol 1997, 99:93-100. Medical Research Council Working Party in Childhood Leukaemia.
21. Secker-Walker L.M., Prentice H.G., Durrant J., Richards S., Hall E., Harrison G. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 1997, 96:601-610. MRC Adult Leukaemia Working Party.
22. Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome: a collaborative study of the Groupe Français de Cytogénétique Hématologique [Erratum in: Blood 1996;88:2818]. Blood 1996, 87:3135-3142.
23. Pui C.H., Carroll A.J., Head D., Raimondi S.C., Shuster J.J., Crist W.M., et al. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood 1990, 76:590-596.
24. Raimondi S.C., Pui C.H., Hancock M.L., Behm F.G., Filatov L., Rivera G.K. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 1996, 10:213-224.
25. Forestier E., Johansson B., Borgström G., Kerndrup G., Johansson J., Heim S. Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. Eur J Haematol 2000, 64:194-200. The NOPHO Leukemia Cytogenetic Study Group.
26. Heerema N.A., Nachman J.B., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999, 94:4036-4045.
27. Pui C.H., Williams D.L., Raimondi S.C., Rivera G.K., Look A.T., Dodge R.K., et al. Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1987, 70:247-253.
28. Wetzler M., Dodge R.K., Mrozek K., Carroll A.J., Tantravahi R., Block A.W., et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood 1999, 93:3983-3993.
29. Groupe Français de Cytogénétique Hématologique Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 1993, 7:10-19.
30. Secker-Walker L.M., Craig J.M., Hawkins J.M., Hoffbrand A.V. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 1991, 5:196-199.
31. Heerema N.A., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., Lange B.J., et al. Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Leuk Lymphoma 2000, 36:467-478.
32. Pedersen R.K., Kerndrup G.B., Sørensen A.G., Mourits-Andersen T., Gram-Hansen P., Pulczynski S., et al. Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the results. Cancer Genet Cytogenet 2001, 128:7-10.
33. Hayashi Y., Raimondi S.C., Look A.T., Behm F.G., Kitchingman G.R., Pui C.H., et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990, 76:1626-1630.
34. Romana S.P., Poirel H., Le Coniat M., Flexor M.A., Mauchauffé M., Jonveaux P., et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995, 86:4263-4269.
35. Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995, 9:1985-1989.
36. Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M.G., Ludwig W.D., Burci L., et al. Associazione Italiana Ematologia Oncologia Pediatrica; Berlin-Frankfurt-Münster Study Group. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 1997, 90:571-577.
37. Aguiar R.C., Sohal J., van Rhee F., Carapeti M., Franklin I.M., Goldstone A.H., et al. MRC Adult Leukaemia Working Party. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. Br J Haematol 1996, 95:673-677.
38. Raynaud S., Mauvieux L., Cayuela J.M., Bastard C., Bilhou-Nabera C., Debuire B., et al. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996, 10:1529-1673.
39. Romana S.P., Le Coniat M., Poirel H., Marynen P., Bernard O., Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996, 10:167-170.
40. Raynaud S., Cavé H., Baens M., Bastard C., Cacheux V., Grosgeorge J., et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996, 87:2891-2899.
41. Stegmaier K., Pendse S., Barker G.F., Bray-Ward P., Ward D.C., Montgomery K.T., et al. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995, 86:38-44.
42. Raimondi S.C., Williams D.L., Callihan T., Peiper S., Rivera G.K., Murphy S.B. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986, 68:69-75.
43. Heerema N.A., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., Nachman J.B., et al. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Cancer 2000, 88:1945-1954.
44. Harewood L., Robinson H., Harris R., Al-Obaidi M.J., Jalali G.R., Martineau M., et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 2003, 17:547-553. on behalf of the Medical Research Council Childhood and Adult Leukaemia Working Parties.
45. Ma S.K., Wan T.S.K., Cheuk A.T.C., Fung L.F., Chan G.C.F., Chan S.Y., et al. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia 2001, 15:1442-1447.
46. Nordgren A., Heyman M., Sahlén S., Schoumans J., Söderhäll S., Nordenskjöld M., et al. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding: implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol 2002, 68:31-41.
47. Attarbaschi A., Mann G., Panzer-Grümayer R., Röttgers S., Steiner M., König M., et al. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Münster (ALL-BFM) trials. J Clin Oncol 2008, 26:3046-3050.
48. Heerema N.A., Sather H.N., Sensel M.G., Liu-Mares W., Lange B.J., Bostrom B.C., et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999, 94:1537-1544.
49. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007, 109:3451-3461.
50. Hayashi Y., Pui C.H., Behm F.G., Fuchs A.H., Raimondi S.C., Kitchingman G.R., et al. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 1990, 76:150-156.
51. Pui C.H., Crist W.M., Look A.T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990, 76:1449-1463.
52. Raimondi S.C., Behm F.G., Roberson P.K., Williams D.L., Pui C.H., Crist W.M., et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990, 8:1380-1388.
53. Secker-Walker L.M. General report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997. Leukemia 1998, 12:776-778. European 11q23 Workshop participants.
54. Rowley J.D. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 1998, 32:495-519.
55. De Braekeleer M., Morel F., Le Bris M.J., Herry A., Douet-Guilbert N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res 2005, 25:1931-1944.
56. Johansson B., Moorman A.V., Haas O.A., Watmore A.E., Cheung K.L., Swanton S., et al. Hematologic malignancies with t(4;11)(q21;q23): a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia 1998, 12:779-787. on behalf of the European 11q23 Workshop participants.